Kelly CybulskiPrincipal Scientist at CytivaSpeaker
Profile
Kelly Cybulski is a Principal Scientist in R&D at Cytiva, where she has spent the past seven years advancing viral vector process and product development. With an MS degree in Cell and Molecular Biology from the University of Rhode Island and two decades of experience spanning good manufacturing practices (GMP) production, process development, and research, Kelly brings deep technical expertise and a proven track record of innovation in biopharmaceutical manufacturing.
Agenda Sessions
Democratizing Gene Therapy: Upstream Innovations to Streamline CMC and Reduce Cost per Dose
, 12:30pmView Session
